Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 8 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 33, revenue growth forecast of -64.0%, and profit growth estimate of -333.1% for FY26, based on top 8 analyst calls.